Page 39 - Sun Pharma

2,839 bottles made by Sun Pharma Inc being recalled in US

The recall is due to failed dissolution specifications

Madras HC orders in favour of Sun Pharma in trademark dispute

The Court issued a permanent injunction against Cadila Healthcare using marks similar to Sun Pharma's particular trademark

Sun Pharma relaunches sunscreen brand to grow OTC business

Suncros will now be sold through both prescription and OTC mode

Sun Pharma launches sunscreen brand Suncros

Company has also signed former Miss India and actress Dia Mirza as Suncros' brand ambassador

Continue to remain opportunistic for acquisitions: Sun Pharma

Shanghvi said process of integrating Ranbaxy with Sun Pharma has commenced with a view to ensure business momentum and drive value creation

Sun Pharma sells two manufacturing plants in US to Frontida BioPharm

Sale part of drug maker's plans to consolidate its manufacturing facilities in US

Sun Pharma's results, forecast disappoint

Add to 'already weak' sentiments

Sun Pharma forecasts annual sales below estimates, shares fall

As it grapples with increased competition in the US as well as supply constraints

Sun Pharma posts results below estimates; stock cracks 4%

However, it posted 92% jump in net profit in Q4 2016 on a y-o-y basis on the back of strong revenue growth.

Sun Pharma expects 8-10% revenue growth in FY 17

Sun Pharma has also proposed a buyback of shares and its board will meet on June 23 to evaluate the proposal

Sun Pharma logs 92% profit growth

Posts Rs 1,713 cr profit, revenue up by 25%

Sun Pharma gets US subpoena over pricing of generic drugs

Department of Justice seeks information on pricing and marketing of generic drugs it sells in the US

Sun Pharma stock up 5.8% over subsidiary Taro's strong quarterly result

Taro reported 8.6% sales growth to $265 million; operating profit rose 18% to $181 million

Sun Pharma takes mobile app route to raise disease awareness: Abhay Gandhi

Q&A with Sun Pharma's India Business CEO

Sun Pharma launches app for asthma patients

The app will help doctors track treatment progress of patients and increase compliance to medication

Sun looks for partner in Japan

Meanwhile, the firm on Wednesday signed an deal with International Centre for Genetic Engineering and Biotechnology to develop a novel botanical drug for treatment of dengue

Sun Pharma says phase-3 trials in skin disorder drug show positive results

The drug, Tildrakizumab, is being developed by Sun Pharma under license from MNC drug major MSD

Sun Pharma partners ICGEB to develop dengue drug

The agreement permits Sun Pharma access to all the intellectual properties of the drug across 17 countrieS

Sun Pharma shares up 2% as it gets approval for non-steroid drug

The stock gained 1.74% to Rs 825.95 on BSE

Sun gets US FDA nod for eye drug

The company, which also launched ophthalmic division in US, earns about half its consolidated revenue from United States